Velivet Triphasic Regimen NDC 0555-9051

NDC codes

FDA NDC Directory

Product NDC (as listed)0555-9051Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00555-9051Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0555-9051-67	00555905167	3 POUCH in 1 CARTON (0555-9051-67) / 1 BLISTER PACK in 1 POUCH (0555-9051-79) / 1 KIT in 1 BLISTER PACKMarketed from Mar 1, 2004

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Velivet Triphasic RegimenSuffix: Triphasic Regimen
Generic name (nonproprietary): desogestrel and ethinyl estradiol
Dosage form: Kit
Labeler: Teva Pharmaceuticals USA, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076455
Marketing start: Mar 1, 2004
Listing expires: Dec 31, 2026
Identifiers: Product ID 0555-9051_855af598-bfc0-4f0b-ab61-d3cb414b86d5SPL ID 855af598-bfc0-4f0b-ab61-d3cb414b86d5SPL set ID a3ce5125-62ba-4983-93f0-91f254271605RxCUI 654353, 729534, 748797, 759741, 759742, 762334

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N400555905167 followed by a unit qualifier and the quantity

Package 00555-9051-67. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 27, 2022. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Velivet (desogestrel and ethinyl estradiol tablets) is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. Oral contraceptives are highly effective. Table 2 lists the typical unintended pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, the IUD, and implants, depends upon the reliability with which they are used. Correct and consistent use of these methods can result in lower failure rates. TABLE 2: PERCENTAGE OF WOMEN EXPERIENCING AN UNINTENDED PREGNANCY DURING THE FIRST YEAR OF TYPICAL USE AND THE F…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)